South Korea
· Delayed Price · Currency is KRW Dongwha Pharm.Co.,Ltd Statistics
Total Valuation
Dongwha Pharm.Co.,Ltd has a market cap or net worth of KRW 215.37 billion. The enterprise value is 228.58 billion.
| Market Cap | 215.37B |
| Enterprise Value | 228.58B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Dongwha Pharm.Co.,Ltd has 27.72 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Shares Outstanding | 27.72M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.42% |
| Owned by Institutions (%) | 9.31% |
| Float | 18.43M |
Valuation Ratios
The trailing PE ratio is 15.48.
| PE Ratio | 15.48 |
| Forward PE | n/a |
| PS Ratio | 0.53 |
| PB Ratio | 0.58 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.09, with an EV/FCF ratio of -15.94.
| EV / Earnings | 16.44 |
| EV / Sales | 0.56 |
| EV / EBITDA | 8.09 |
| EV / EBIT | 18.58 |
| EV / FCF | -15.94 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.38 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | -2.72 |
| Interest Coverage | 11.70 |
Financial Efficiency
Return on equity (ROE) is 3.42% and return on invested capital (ROIC) is 1.79%.
| Return on Equity (ROE) | 3.42% |
| Return on Assets (ROA) | 1.46% |
| Return on Capital (ROIC) | 1.79% |
| Revenue Per Employee | 511.66M |
| Profits Per Employee | 17.53M |
| Employee Count | 793 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 3.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.85% in the last 52 weeks. The beta is 1.06, so Dongwha Pharm.Co.,Ltd's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -22.85% |
| 50-Day Moving Average | 7,975.80 |
| 200-Day Moving Average | 8,805.05 |
| Relative Strength Index (RSI) | 44.50 |
| Average Volume (20 Days) | 57,323 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dongwha Pharm.Co.,Ltd had revenue of KRW 405.75 billion and earned 13.90 billion in profits. Earnings per share was 501.80.
| Revenue | 405.75B |
| Gross Profit | 200.51B |
| Operating Income | 12.17B |
| Pretax Income | 19.52B |
| Net Income | 13.90B |
| EBITDA | 28.12B |
| EBIT | 12.17B |
| Earnings Per Share (EPS) | 501.80 |
Balance Sheet
The company has 62.06 billion in cash and 39.05 billion in debt, giving a net cash position of 23.01 billion or 830.23 per share.
| Cash & Cash Equivalents | 62.06B |
| Total Debt | 39.05B |
| Net Cash | 23.01B |
| Net Cash Per Share | 830.23 |
| Equity (Book Value) | 410.21B |
| Book Value Per Share | 13,492.75 |
| Working Capital | 131.22B |
Cash Flow
In the last 12 months, operating cash flow was 12.91 billion and capital expenditures -27.25 billion, giving a free cash flow of -14.34 billion.
| Operating Cash Flow | 12.91B |
| Capital Expenditures | -27.25B |
| Free Cash Flow | -14.34B |
| FCF Per Share | -517.27 |
Margins
Gross margin is 49.42%, with operating and profit margins of 3.00% and 3.43%.
| Gross Margin | 49.42% |
| Operating Margin | 3.00% |
| Pretax Margin | 4.81% |
| Profit Margin | 3.43% |
| EBITDA Margin | 6.93% |
| EBIT Margin | 3.00% |
| FCF Margin | -3.53% |
Dividends & Yields
This stock pays an annual dividend of 180.00, which amounts to a dividend yield of 2.33%.
| Dividend Per Share | 180.00 |
| Dividend Yield | 2.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 35.89% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 2.23% |
| Earnings Yield | 6.46% |
| FCF Yield | -6.66% |
Stock Splits
The last stock split was on June 30, 2009. It was a forward split with a ratio of 5.
| Last Split Date | Jun 30, 2009 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Dongwha Pharm.Co.,Ltd has an Altman Z-Score of 2.88. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.88 |
| Piotroski F-Score | n/a |